Holen Sie sich die Stockscreener-App
5.27
0.75%
-0.04
Handel nachbörslich:
5.27
Schlusskurs vom Vortag:
$5.31
Offen:
$5.31
24-Stunden-Volumen:
579.08K
Relative Volume:
0.85
Marktkapitalisierung:
$360.58M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-96.66M
KGV:
-2.4512
EPS:
-2.15
Netto-Cashflow:
$-83.73M
1W Leistung:
+5.82%
1M Leistung:
+13.33%
6M Leistung:
+9.11%
1J Leistung:
-57.94%
1-Tages-Spanne:
$5.13
$5.47
1-Wochen-Bereich:
$4.47
$5.58
52-Wochen-Spanne:
$2.86
$13.93
Olema Pharmaceuticals Inc Stock (OLMA) Company Profile
Firmenname
Olema Pharmaceuticals Inc
Sektor
Branche
Telefon
(415) 651-3316
Adresse
780 BRANNAN STREET, SAN FRANCISCO
Vergleichen Sie OLMA mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
OLMA
Olema Pharmaceuticals Inc
|
5.27 | 312.69M | 0 | -96.66M | -83.73M | -2.15 |
|
VRTX
Vertex Pharmaceuticals Inc
|
395.92 | 99.42B | 11.42B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
561.55 | 58.99B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
432.52 | 56.35B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
646.60 | 39.02B | 3.05B | 1.28B | -614.78M | 19.58 |
|
ONC
Beone Medicines Ltd Adr
|
307.51 | 34.25B | 3.81B | -644.79M | -669.77M | -6.24 |
Olema Pharmaceuticals Inc Stock (OLMA) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2024-04-02 | Eingeleitet | Goldman | Buy |
| 2024-01-30 | Eingeleitet | Citigroup | Buy |
| 2023-07-21 | Eingeleitet | Oppenheimer | Outperform |
| 2023-05-05 | Eingeleitet | CapitalOne | Overweight |
| 2023-02-22 | Eingeleitet | Credit Suisse | Outperform |
| 2022-07-06 | Fortgesetzt | Canaccord Genuity | Buy |
| 2022-06-09 | Hochstufung | H.C. Wainwright | Neutral → Buy |
| 2022-02-28 | Eingeleitet | H.C. Wainwright | Neutral |
| 2021-12-07 | Fortgesetzt | Cowen | Outperform |
| 2020-12-14 | Eingeleitet | Canaccord Genuity | Buy |
| 2020-12-14 | Eingeleitet | Cowen | Outperform |
| 2020-12-14 | Eingeleitet | JP Morgan | Overweight |
| 2020-12-14 | Eingeleitet | Jefferies | Buy |
Alle ansehen
Olema Pharmaceuticals Inc Aktie (OLMA) Neueste Nachrichten
Identifying reversal signals in Olema Pharmaceuticals Inc.2025 Geopolitical Influence & Verified Momentum Stock Alerts - Newser
What institutional flow reveals about Olema Pharmaceuticals Inc.Analyst Upgrade & Community Verified Watchlist Alerts - Newser
Citigroup Forecasts Strong Price Appreciation for Olema Pharmaceuticals (NASDAQ:OLMA) Stock - MarketBeat
What’s next for Olema Pharmaceuticals Inc. stock price2025 Market Outlook & Growth Focused Investment Plans - Newser
Published on: 2025-08-13 05:28:51 - Newser
Volatility clustering patterns for Olema Pharmaceuticals Inc.Weekly Gains Report & Growth Focused Entry Point Reports - Newser
Olema Pharmaceuticals (NASDAQ:OLMA) Price Target Raised to $21.00 at Citigroup - Defense World
Clinical Trial Progress and Analyst Endorsement Spark Short-Term Rebound for Olema Pharmaceuticals - Insider Monkey
Olema Pharmaceuticals (NASDAQ:OLMA) Issues Quarterly Earnings Results - MarketBeat
What makes Olema Pharmaceuticals Inc. stock price move sharplyReal-Time Entry Signals for Top Stocks - Newser
Olema Pharmaceuticals Advances Breast Cancer Therapies - TipRanks
Is Olema Pharmaceuticals Inc. a defensive stockAI Curated Investment Watch - thegnnews.com
Olema Pharmaceuticals Stays On Track Despite Wider Losses - Finimize
Olema Pharma Q2 net loss widens to $43.8 mln - MarketScreener
Olema Oncology Reports Second Quarter 2025 Financial and Operating Results - GlobeNewswire
Can Olema Pharmaceuticals Inc. Outperform Peers After Recent PullbackHigh Probability Trade Forecast Summary - beatles.ru
Momentum divergence signals in Olema Pharmaceuticals Inc. chartCapital Growth Summary Over Five Years - Newser
What to expect from Olema Pharmaceuticals Inc. in the next 30 daysSmart Entry Watchlist with Daily Analysis - Newser
Does Olema Pharmaceuticals Inc. qualify in momentum factor screeningMomentum Prediction Based on AI Backtesting - Newser
Key metrics from Olema Pharmaceuticals Inc.’s quarterly dataTechnical Safety Zone Pattern Recognition - Newser
Is a relief rally coming for Olema Pharmaceuticals Inc. holdersTrend Reversal Probability Forecast Update - Newser
Combining price and volume data for Olema Pharmaceuticals Inc.Weekly Price Target Forecast and Alerts - Newser
11 Best Short-Term Stocks to Invest in - Insider Monkey
Trendlines Converge — Decision Point for Olema Pharmaceuticals Inc.Consistent Income Focused Trade List Analyzed - beatles.ru
Applying Elliott Wave Theory to Olema Pharmaceuticals Inc.Neural Model for Stock Price Movement - Newser
How to use a screener to detect Olema Pharmaceuticals Inc. breakoutsDaily Stock Watch Summary with Key Insights - Newser
Why Olema Pharmaceuticals Inc. stock attracts strong analyst attentionFundamental Forecast for Undervalued Stocks - Newser
Can a trend reversal in Olema Pharmaceuticals Inc. lead to recoveryRisk Managed Watchlist with Breakout Picks - Newser
Olema Pharmaceuticals Inc expected to post a loss of 38 cents a shareEarnings Preview - TradingView
Backtesting results for Olema Pharmaceuticals Inc. trading strategies5-Year Price Trend Summary and Analysis - Newser
Understanding Olema Pharmaceuticals Inc.’s price movementFree Opportunity Map for Daily Stock Trading - Newser
Olema Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - GlobeNewswire
Olema Oncology Awards $693K in Stock Options as Part of Strategic Hiring Initiative - Stock Titan
Trading Bots Trigger Alerts on Olema Pharmaceuticals Inc. ActivityShort Window Trade Insight Summary - beatles.ru
Should I hold or sell Olema Pharmaceuticals Inc. stock in 2025Build a portfolio for long-term financial success - Jammu Links News
How hedge fund analytics apply to Olema Pharmaceuticals Inc. stockSummary of Long-Term Buy Zone Stocks - Newser
What are the technical indicators suggesting about Olema Pharmaceuticals Inc.Tremendous growth opportunities - Jammu Links News
What is Olema Pharmaceuticals Inc. company’s growth strategyCapitalize on strong market momentum - Jammu Links News
Finanzdaten der Olema Pharmaceuticals Inc-Aktie (OLMA)
Umsatz
Nettogewinn
Free Cashflow
ENV
1.67%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):